Granulators for Pharmaceutical Market Witnesses Significant Boom as Demand for Safe Medicines Increases
It has been suggested by experts that the granulation form for pharmaceutical capsules be used as a generic format for all pharmaceutical products. This would remove the cost factor associated with production of granulating tablets from tablet and capsule production line. These tablets are made available to the market at an affordable price in low volumes. Moreover, granulation helps in increasing the shelf life of tablets, minimize wastage and enhance the quality and usefulness of medicines. Such benefits are expected to propel growth of the granulators for pharmaceutical market.
Currently,
the granulators for pharmaceutical market is booming as the demand for safe
medicines increases. Coherent Market Insight’s reports show that this forecast
will continue to grow exponentially as new tablets are manufactured and the
demand for safe medicines increases.
Granulation
of pharmaceuticals is one of the
most significant unit operations in the production of pharmaceutical dosage
forms, mostly tablets and capsules. Granules are produced to enhance the
uniformity of the API in the final product. Other advantages of granulation include,
increase in the density of the blend and reduction in dust during granulation
process to reduce toxic exposure and process-related hazards. It also offers metering
or volumetric dispensing and improves the appearance of the product. Such
advantages are expected to aid in growth of the granulators for pharmaceutical
market.
The
growth of tablet manufacturing industry in Asia Pacific region has triggered an
increase in demand for safe and cost effective tablets in the pharmaceutical
market. Moreover, it has led to the diversification of product types i.e.
single as well as double dosage tablets. Such scenario has enabled pharmaceutical
manufacturers to enter granulators for pharmaceutical market in lucrative
terms.
Europe
is also expected to witness significant growth in the granulators for
pharmaceutical market due to increasing investment in R&D of new
pharmaceuticals. According to The European Federation of Pharmaceutical
Industries and Associations’ Key Data 2019, the pharmaceutical sector in Europe
invested US$ 19, 509 million in 2000, which increased to US$ 39,895 million
(est.) in 2018.
The
productivity in pharmaceutical plants based in the Americas is expected to grow
at a more rapid rate than the ones based in the Middle East and Asia Pacific.
The major drivers behind this are better availability of ingredients. In
addition, high prevalence of chronic diseases in the region is expected to
boost demand for various pharmaceuticals, thereby propelling growth of the granulators
for pharmaceutical market.
Comments
Post a Comment